Genetic alterations in ERBB2-amplified breast carcinomas

Clinical Cancer Research

Volumn 5, Issue 12, 1999, Pages 4140-4145

  Isola, Jorma ^a   Chu, Lisa ^b   DeVries, Sandy ^b   Matsumura, Kouji ^b   Chew, Karen ^b   Ljung, Britt Marie ^c   Waldman, Frederic M ^c,d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CHROMOSOME ABERRATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; TUMOR CELLS, CULTURED;

EID: 0033377721     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Slamon, D. J., Godolphin, W., and Jones, L. A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
2. Ravdin, P., and Chamness, G. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene, 159: 19-27, 1995.
3. Borg, A., Sigurdsson, H., Clark, G. M., Ferno, M., Fuqua S., Olsson, H., Killander, D., and McGuire, W. L. C-erbB2 amplification in breast cancer with a high rate of proliferation. Oncogene, 6: 137-143, 1991.
4. Kallioniemi, O. P., Holli, K., Visakorpi, T., Koivula, T., Helin, H., and Isola, J. Association of erbB-2 overexpression with high rate of cell proliferation, increased risk of visceral metastasis, and poor long term survival in breast cancer. Int. J. Cancer, 49: 650-655, 1991.
5. Paik, S., Bryant, J., Park, C., Fisher, B., Tan-Chiu, E., Hyams, D., Fisher, E. R., Lippman, M. E., Wickerham, D. L., and Wolmark, N. ErbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J. Natl. Cancer Inst., 90: 1361-1370, 1998.
6. Muss, H. B., Thor, A. D., Berry, D. A., Kute, T., Liu, E. T., Koerner, F., Cirrincione, C. T., Budman, D. R., Wood, W. C., Barcos, M., and Henderson, I. C. C-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N. Engl. J. Med., 330: 1260-1266, 1994.
7. Thor, A. D., Berry, D. A., Budman, D. R., Muss, H. B., Kute, T., Henderson, I. C., Barcos, M., Cirrincione, C., Edgerton, S., Allred, C., Norton, L., and Liu, E. T. erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. J. Natl. Cancer Inst., 90: 1346-1360, 1998.
8. Clark, G. M. Should selection of adjuvant chemotherapy for patients with breast cancer be based on erbB-2 status? J. Natl. Cancer Inst., 90: 1320-1321, 1998.
9. Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L-C., Smith, H. S., Waldman, F., Pinkel, D., and Gray, J. W. C-erbB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA, 89: 5321-5325, 1992.
10. Pauletti, G., Godolphin, W., Press, M. F., and Slamon, D. J. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene, 13: 63-72, 1996.
11. Press, M. F., Bernstein, L., Thomas, P. A., Meisner, L. F., Zhou, J. Y., Ma, Y., Hung, G., Robinson, R. A., Harris, C., El-Naggar, A., Slamon, D. J., Phillips, R. N., Ross, J. S., Wolman, S. R., and Flom, K. J. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J. Clin. Oncol., 15: 2894-2904, 1997.
12. Kallioniemi, A., Kallioniemi, O. P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
13. Nishizaki, T., DeVries, S., Chew, K., Goodson, W. H., III., Ljung, B. M., Thor, A., and Waldman, F. M. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer, 19: 267-272, 1997.
14. Tirkkonen, M., Tanner, M., Karhu, R., Kallioniemi, A., Isola, J., and Kallioniemi, O. P. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer, 21: 177-184, 1998.
15. Courjal, F., and Theillet, C. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res., 57: 4368-4377, 1997.
16. Barlund, M., Tirkkonen, M., Forozan, F., Tanner, M. M., Kallioniemi, O., and Kallioniemi, A. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes Cancer, 20: 372-376, 1997.
17. Kallioniemi, O. P., Kallioniemi, A., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Gray, J. W., Pinkel, D., and Waldman, F. M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA, 91: 2156-2160, 1994.
18. Kallioniemi, A., Kallioniemi, O. P., Citro, G., Sauter, G., DeVries, S., Kerschmann, R., Caroll, P., and Waldman, F. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer, 12: 213-219, 1995.
19. Isola, J., Kallioniemi, O. P., Chu, L., Fuqua, S., Hilsenbeck, S., Osborne, K., and Waldman, F. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am. J. Pathol., 147: 905-911, 1995.
20. Cornelisse, C. J., Kuipers-Dijkshoorn, N., van Vliet, M., Hermans, J., and Devilee, P. Fractional allelic imbalance in human breast cancer increases with tetraploidization and chromosome loss. Int. J. Cancer, 50: 544-548, 1992.
21. Devilee, P., and Cornelisse, C. J. Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta, 1198: 113-130, 1994.
22. Tanner, M. M., Tirkkonen, M., Kallioniemi, A., Collins, C., Stokke, T., Karhu, R., Kowbel, D., Shadravan, F., Hintz, M., Kuo, W. L., Waldman, F. M., Isola, J. J., Gray, J. W., and Kallioniemi, O. P. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res., 54: 4257-4260, 1994.
23. Tanner, M. M., Tirkkonen, M., Kallioniemi, A., Isola, J., Kuukasjarvi, T., Collins, C., Kowbel, D., Guan, X. Y., Trent, J., Gray, J. W., Meltzer, P., and Kallioniemi, O. P. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res., 56: 3441-3445, 1996.
24. Frank C. J., McClatchey, K. D., Devaney, K. O., and Carey, T. E. Evidence that loss of chromosome 18q is associated with tumor progression. Cancer Res., 57: 824-827, 1997.
25. Tomasetto, C., Regnier, C., Moog-Lutz, C., Mattei, M., Chenard, M., Lidereau, R., Basset, P., and Rio, M. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics, 28: 367-376, 1995.
26. Press, M. F., Hung, G., Godolphin, W., and Slamon, D. J. Sensitivity of HER-2/neu in archival tissue samples: potential source of error immunohistochemical studies of oncogene expression. Cancer Res., 54: 2771-2777, 1994.
27. HER-2 overexpression, and intratumor heterogeneity in human breast cancer. Cancer Res., 55: 5400-5407, 1995.
28. Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., and Kallioniemi, O. P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med., 4: 844-847, 1998.
29. Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W. L., Chen, C., Zhai, Y., Dairkee, S. H., Ljung, B. M., Gray, J. W., and Albertson, D. G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet., 20: 207-211, 1998.